Cancer ScreeningMar 22, 2026
The Galleri test screens for signals from over 50 types of cancer using a single blood draw. It works by analyzing cell-free DNA methylation patterns, and the clinical data behind it is both genuinely promising and genuinely limited. The CCGA validation study showed 99.5% specificity and the ability to predict where a cancer signal originates with 88.7% accuracy. But sensitivity for Stage I cancers was just 16.8%, meaning the test misses most cancers at their earliest, most treatable point. If you're considering spending $849 on this test, you deserve a clear picture of what the science actually shows.
Metabolic HealthMar 22, 2026
Most doctors check fasting glucose or HbA1c at annual physicals. If those numbers look normal, you're told your blood sugar is fine. But insulin resistance, the metabolic dysfunction that precedes type 2 diabetes by years or even decades, doesn't show up on a glucose test until the damage is well underway. By the time glucose rises, the pancreas has already been overproducing insulin to compensate, sometimes for a decade or more. The right insulin resistance test can catch this process early, when it's still fully reversible.
Heart HealthMar 22, 2026
Standard cholesterol panels measure how much cholesterol sits inside your LDL particles. But cardiovascular risk depends on the number of atherogenic particles circulating in your blood, not the cholesterol mass they carry. The ApoB test measures that particle count directly. Over the past decade, evidence from genetic studies, prospective cohorts, and clinical trials has shown that ApoB predicts cardiovascular events more accurately than LDL cholesterol (LDL-C) alone, particularly in people with metabolic syndrome, insulin resistance, or elevated triglycerides.
Blood TestingMar 21, 2026
Most annual physicals include a basic metabolic panel and a complete blood count. These tests cover electrolytes, kidney function, liver enzymes, and blood cell counts. They are useful for detecting acute illness and organ dysfunction. But they tell you almost nothing about cardiovascular risk, metabolic health, thyroid function, inflammation, or vitamin status. For anyone who wants to catch problems early, rather than after symptoms develop, standard panels leave too much unmeasured.
Metabolic HealthMar 21, 2026
Most routine blood work checks glucose but skips insulin entirely. That is a problem, because insulin levels start climbing years before glucose goes out of range. By the time fasting glucose hits 100 mg/dL, the pancreas may have been overproducing insulin for a decade or more to compensate for growing resistance in muscle, liver, and fat tissue. A fasting insulin test captures this early signal directly, offering a window into metabolic health that glucose alone cannot provide.
Gut HealthMar 21, 2026
If you have been dealing with bloating, food sensitivities, or persistent fatigue, you have probably considered a gut health stool test. The problem is that the market is flooded with options ranging from clinically validated diagnostic panels to consumer microbiome kits that promise personalized diet advice based on shaky science. Not all stool tests measure the same things, and not all of them produce actionable results. This guide breaks down what the research actually supports, which biomarkers have strong diagnostic evidence, and where the science falls short.
